Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SurForce is a biotechnology company specializing in mechanobiology-based solutions for cell culture and stem cell research. Spun out from the University of Michigan, the company develops synthetic substrates that utilize mechanical forces and surface topography to precisely control cell behavior, including adhesion, proliferation, and differentiation. Their technology aims to improve the efficiency and scalability of stem cell manufacturing and provide more physiologically relevant models for drug screening and regenerative medicine. By replacing complex biological coatings with defined synthetic surfaces, SurForce provides researchers and manufacturers with greater reproducibility and control over cell-based products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SurForce.